Atlas Trials

The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses

Clinical trial NCT03642860 · COMPLETED

Trial details

NCT number
NCT03642860
Sponsor
Rigshospitalet, Denmark
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tarui DiseaseDebrancher DeficiencyGYG1 DEFICIENCY
Start date
2018-08-15
Primary completion
2019-08-28
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.